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Bullous Cutaneous Larva Migrans
Cutaneous larva migrans (CLM) is one of the most 
common skin diseases among travelers returning 
from the tropics (1,2). The disease is endemic on Ca-
ribbean islands, in Africa, South America, Southeast 
Asia, and the central and southeastern states of the 
US. In Europe, only sporadic cases have been reported 
among travelers returning from tropical countries.
CLM is clinically characterized by slightly raised 
and erythematous single or multiple, linear or serpig-
inous tracks occurring on the feet or other exposed 
sites. Bullous CLM is a rare form of CLM. Diagnosis is 
usually made from the patient’s history and the char-
acteristic clinical appearance of the lesions (3).
A 53-year-old man presented with a one-month 
history of intense pruritus on the back surface of his 
right foot associated with multiple bullous lesions lo-
calized on the fourth finger of the right foot. The pa-
tient reported good general health and no systemic 
therapy; four weeks before, he had returned from a 
trip to Mexico. The patient denied application of any 
topical medicaments on the lesions.
Dermatologic examination revealed the pres-
ence of multiple blisters, round or oval in shape, with 
a clear serous fluid. A serpiginous, linear track was 
visible (Fig. 1). General physical examination did not 
reveal any pathologic finding. Laboratory tests were 
normal including eosinophil count, total IgE, inflam-
matory tests, stool microscopy and culture, and x-ray. 
Cytological examination of a blister showed the pres-
ence of a mixture of inflammatory cells with a pre-
dominance of eosinophils. Based on clinical history 
and features, a diagnosis of bullous CLM was made. 
The patient was treated with oral albendazole (400 
mg/day for 7 days) and at 3-week follow-up, the erup-
tion had resolved completely.
CLM, also known as creeping eruption, ground 
itch, plumber’s itch, sand worms and linear serpigi-
nous dermatitis, is a dermatitis caused by filariform 
larvae of zoonotic hookworms. In contrast to human 
hookworms, they complete their life cycle in animals 
and use humans as incidental dead-end hosts (4). The 
most common cutaneous hookworms are the cat and 
dog hookworms, Ancylostoma braziliensis and Ancy-
lostoma caninum, respectively, which live in the intes-
tines of cats and dogs. CLM may rarely be caused by 
Uncinaria stenocephala, Bunostomum phlebotomum 
and Ancylostoma ceylonicum (4). 
The hookworm eggs are passed with stools onto 
sandy warm soil, which serves as a rich incubator. The 
eggs feed on soil bacteria and 24 hours later mature 
into non-infectious rhabdoid larvae. After one week, 
they mature into infectious filariform larvae (4). The 
larvae then penetrate intact human skin that comes 
in contact with the infected soil. Initially, the patient 
has a tingling or prickling sensation. Several hours 
later, a reddish-brown pruritic papule develops. The 
erythematous site is usually located 3 to 4 cm away 
from the penetration site, as they travel along the epi-
dermis, creating characteristic serpiginous lesions. Fi-
nally, the larvae die and are resorbed. Thus, larva mi-
grans is self-limiting in most cases.
The bullous form of CLM is rare; in the literature, 
we found only six cases of frankly bullous CLM (4). 
Figure 1. Serpiginous, erythematous track associ-
ated with multiple blisters on the right foot.
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The pathogenesis of blister development is unknown, 
some authors hypothesize that blisters might be the 
result of a delayed hypersensitivity reaction due to 
the release by larvae of unknown antigens or because 
of the release by larvae of lytic enzymes (4,5). 
Cutaneous larva migrans can be treated with topi-
cal application of thiabendazole or cryotherapy. Sys-
temic drugs such as thiabendazole, albendazole and 
ivermectin, represent the first choice in the treatment 
of the bullous form of CLM.
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